跳至主要内容
临床试验/NCT04207554
NCT04207554已完成不适用

Clinical Investigation for the Preview® hCG Urine/Serum Combo Pregnancy Test

Guangzhou Wondfo Biotech Co., Ltd6 个研究点 分布在 1 个国家目标入组 132 人开始时间: 2019年12月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
132
试验地点
6
主要终点
Overall percent (%) agreement

研究概览

简要总结

The objective of this study is to evaluate the agreement of the test device (Preview® hCG Urine/Serum Combo Pregnancy Test) with the predicate device, the QuickVue+ hCG Combo Test.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Healthy adult women of childbearing age.
  • Who either request a pregnancy test, or require a pregnancy test for diagnostic studies or treatment.
  • Signed and dated informed consent.

排除标准

  • Adults who are unable to independently give consent for study.
  • Known pregnancy (i.e. - patient appears obviously pregnant).
  • Recent miscarriage or abortion and yet to have 2 complete menstrual cycles before study start.
  • History of ectopic pregnancy, fibroids, congenital uterine anomaly that causes an irregular-shaped uterus.
  • Taken any of the medications of contraceptives containing estrogen in last two weeks.
  • Hemodynamically unstable.
  • Moderately to severely ill-appearing or in moderate to severe pain.
  • Technically not possible to obtain blood or urine from the study subject.

结局指标

主要结局

Overall percent (%) agreement

时间窗: 3 months

The primary endpoint is the overall percent (%) agreement, which is the percentage of total subjects where the test (Preview® hCG Urine/Serum Combo Pregnancy Test) and the reference test (QuickVue+ hCG Combo Test) agree.

次要结局

  • Positive and negative percent agreement(3 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验